Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis.
about
Pharmacotherapeutic options for hepatitis B.Hepatitis B: treatment choice and monitoring for response and resistance.When can we stop nucleoside analogues in patients with chronic hepatitis B?The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection.α-Fetoprotein level-dependent early hepatitis B surface antigen decline during entecavir therapy in chronic hepatitis B with hepatitis flare.Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance--author's reply.Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance.Great and rapid HBsAg decline in patients with on-treatment hepatitis flare in early phase of potent antiviral therapy.Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.
P2860
Q38631076-E4573C9E-40B3-4D7D-8FC2-3580F72F9C3FQ38707903-842880E8-7587-471A-8FEF-8F497E9B87CDQ39067306-B743DB0A-F5D7-49AF-8BE2-74F480EF052FQ40157059-C53B05AF-1B9E-47C2-8994-D676ACA9B6C0Q40361006-6F07D663-1901-481E-B632-EBE086A1C9CDQ40717249-1588F464-8D4B-4F38-A687-FD6E56AA4186Q40769626-BEE3A2B3-7371-4B2B-9473-B5E8D4CD0B27Q45338507-387E1BC0-D978-43A2-9123-3645D1ABFDCDQ45338510-7176303D-A93D-4B80-8DAD-29A6A14F5653Q47570782-66D2972B-8614-4022-BA24-6B51EF93FB4EQ50849376-A65FF1B6-4935-483A-A4DD-D498C590206C
P2860
Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@en
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@nl
type
label
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@en
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@nl
prefLabel
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@en
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@nl
P2093
P2860
P356
P1476
Clinical outcomes after interr ...... ts with compensated cirrhosis.
@en
P2093
P2860
P304
P356
10.1111/APT.13409
P407
P577
2015-09-18T00:00:00Z